Soliton, Inc.

Soliton, Inc. is a medical device company based in Houston, Texas, that focuses on innovative acoustic shockwave technology. Founded in 2012 and publicly traded on Nasdaq under the ticker symbol SOLY, Soliton is in the pre-revenue stage and is dedicated to developing its proprietary platform for dermatological applications. The company's flagship product, RESONIC™, utilizes rapid pulses of acoustic shockwaves to enhance tattoo removal when used with existing laser treatments. This technology allows for multiple treatments in a single office visit, significantly reducing the time needed for tattoo removal. RESONIC™ is also FDA-cleared for treating cellulite, providing a non-invasive method to address the causes of dimples and ridges associated with the condition. Soliton collaborates with medical device manufacturers and designers to refine its technology and is actively seeking regulatory approvals for additional uses and international markets.

• Employees13
• Founded2012
• Total Funding$12450003